GRETCHEN DAVIS: Open Payments
NPI 1891182267 · LEES SUMMIT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$769 in 29 payments from 9 companies in 2025. Trend: 2023 $257 · 2024 $487 · 2025 $769
Food & beverage: $769
| Company | Payments | Amount |
|---|---|---|
| Viatris Specialty LLC | 11 | $291 |
| Otsuka America Pharmaceutical, Inc. | 9 | $158 |
| ACADIA Pharmaceuticals Inc | 1 | $101 |
| Lundbeck LLC | 3 | $84 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $41 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
| Exact Sciences Corporation | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
Products named: YUPELRI, REXULTI, NUPLAZID, COBENFY, The Cologuard Plus Collection Kit, GVOKE HYPOPEN, Kerendia.
Industry payments across MO — which companies pay providers there.
